And its a tough one, because everyone can respond differently to medicines
Wegovy 7.2 mg The STEP UP trial found that patients on Wegovy 7.2 mg lost an average of 20.7% of their body weight after 72 weeks, compared with 17.5% on the standard 2.4 mg dose
However, it may not be as stable as S-Acetyl L Glutathione
Earlier versions of GLP-1 drugs, such as exenatide (Byetta), increased the risk for pancreatic cancer or certain types of thyroid cancer and even instances of autoimmunity
Understanding where it fits among the best options available , how it compares to bioactive precision peptides , and what stacking approaches researchers are studying gives you the full picture
Its antioxidant and detoxification properties could mitigate the effects of oxidative stress associated with these conditions